Rare
lephants
Screener
Toggle theme
ProPhase Labs, Inc.
PRPH
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2013
FY2009
Total Cash from Operations:
$29.0M
Line Item
Value
% of Total
Capital Expenditures
$3.7M
12.9%
Dividends Paid
$9.4M
32.2%
Stock Repurchases
$2.2M
7.4%
Other Financing
$13.3M
45.9%
Net Cash Flow
$451.0K
1.6%
Download CSV
